Literature DB >> 19740910

Mitochondrial toxicity in HIV-infected patients both off and on antiretroviral treatment: a continuum or distinct underlying mechanisms?

Anne Maagaard1, Dag Kvale.   

Abstract

Mitochondrial toxicity contributes to serious adverse effects observed in HIV-infected individuals treated with nucleoside reverse transcriptase inhibitors (NRTIs). However, similar mitochondrial abnormalities have recently been found even in treatment-naive patients, suggesting that chronic HIV per se could contribute to the toxicity observed in NRTI-exposed individuals. This review gives a current status of the field, with particular focus on recent observations suggesting that distinct mechanisms might cause such toxicity in both NRTI-exposed individuals and those naive to antiretroviral treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19740910     DOI: 10.1093/jac/dkp316

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  27 in total

1.  Association between retinal nerve fiber layer thickness and abnormalities of vision in people with human immunodeficiency virus infection.

Authors:  Partho S Kalyani; Gary N Holland; Amani A Fawzi; Tiago E F Arantes; Fei Yu; Alfredo A Sadun
Journal:  Am J Ophthalmol       Date:  2012-01-15       Impact factor: 5.258

Review 2.  Pharmacokinetic optimization of antiretroviral therapy in children and adolescents.

Authors:  Michael N Neely; Natella Y Rakhmanina
Journal:  Clin Pharmacokinet       Date:  2011-03       Impact factor: 6.447

3.  Antiretroviral neurotoxicity.

Authors:  Kevin Robertson; Jeff Liner; Rick B Meeker
Journal:  J Neurovirol       Date:  2012-07-19       Impact factor: 2.643

4.  Safety of tenofovir use during pregnancy: early growth outcomes in HIV-exposed uninfected infants.

Authors:  George K Siberry; Paige L Williams; Hermann Mendez; George R Seage; Denise L Jacobson; Rohan Hazra; Kenneth C Rich; Raymond Griner; Katherine Tassiopoulos; Deborah Kacanek; Lynne M Mofenson; Tracie Miller; Linda A DiMeglio; D Heather Watts
Journal:  AIDS       Date:  2012-06-01       Impact factor: 4.177

5.  Antiviral activity of genital tract secretions after oral or topical tenofovir pre-exposure prophylaxis for HIV-1.

Authors:  Betsy C Herold; Charlene S Dezzutti; Barbra A Richardson; Jeanne Marrazzo; Pedro M M Mesquita; Colleen Carpenter; Ashley Huber; Nicolette Louissaint; Mark A Marzinke; Sharon L Hillier; Craig W Hendrix
Journal:  J Acquir Immune Defic Syndr       Date:  2014-05-01       Impact factor: 3.731

6.  Oxidative mitochondrial DNA damage in peripheral blood mononuclear cells is associated with reduced volumes of hippocampus and subcortical gray matter in chronically HIV-infected patients.

Authors:  Kalpana J Kallianpur; Mariana Gerschenson; Brooks I Mitchell; Daniel E LiButti; Tracie M Umaki; Lishomwa C Ndhlovu; Beau K Nakamoto; Dominic C Chow; Cecilia M Shikuma
Journal:  Mitochondrion       Date:  2016-02-23       Impact factor: 4.160

Review 7.  Heart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive Considerations.

Authors:  Mabel Toribio; Tomas G Neilan; Markella V Zanni
Journal:  Curr HIV/AIDS Rep       Date:  2019-10       Impact factor: 5.071

8.  Analyses of Mitochondrial DNA and Immune Phenotyping Suggest Accelerated T-Cell Turnover in Treated HIV.

Authors:  Marta Massanella; Maile Y Karris; Josué Pérez-Santiago; Christina Yek; Andrej Vitomirov; Sanjay R Mehta
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

9.  Impact of age on markers of HIV-1 disease.

Authors:  Vanessa Pirrone; David J Libon; Christian Sell; Chad A Lerner; Michael R Nonnemacher; Brian Wigdahl
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

10.  PharmGKB summary: zidovudine pathway.

Authors:  Yogita Ghodke; Peter L Anderson; Katrin Sangkuhl; Jatinder Lamba; Russ B Altman; Teri E Klein
Journal:  Pharmacogenet Genomics       Date:  2012-12       Impact factor: 2.089

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.